In the latest round of rejig of the 30-share pack, Tata Group’s automobile arm Tata Motors will replace the drug major Dr Reddy’s Laboratories, said an report from Nuvama Alternative and Quantitative Research.

Leave a Reply

Your email address will not be published. Required fields are marked *

Generated by Feedzy